Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
IDNAvsTMEDETF Comparison
iShares Genomics Immunology and Healthcare ETF (IDNA) belongs to the BioTech & Genomics segment. T. Rowe Price Health Care ETF (TMED) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. IDNA is more expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.44% for TMED. IDNA is up 14% year-to-date (YTD) with +$5M in YTD flows. TMED performs worse with 0.13% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IDNA and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IDNA vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IDNA TMED | +2.96%+1.16% | +12.62%+1.57% | +14.00%+0.13% | +39.25%n/a | +33.46%n/a | -34.44%n/a |
| Flows | IDNA TMED | +$5M+$1M | +$5M+$4M | +$5M+$3M | +$293K- | -$22M- | -$964K- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IDNA TMED | +22.83%+16.57% | +25.56%n/a | +24.01%n/a | +28.14%n/a |
| Max drawdown | IDNA TMED | -6.17%-7.14% | -18.64%n/a | -30.61%n/a | -68.19%n/a |
| Max drawdown duration | IDNA TMED | 29d47d | 127dn/a | 279dn/a | 1634dn/a |
IDNA | TMED | |
Last sale 3/11/2026 at 7:59 PM | $29.96 | $29.48 |
| Previous close 03/11/2026 | $29.85 | $29.70 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IDNA | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IDNA | TMED | |
|---|---|---|
| Last price | $29.96 | $29.48 |
| 1D performance | +0.37% | -0.73% |
| AuM | $153.72 M | $19.32 M |
| E/R | 0.47% | 0.44% |
IDNA | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | T. Rowe Price |
| Benchmark | NYSE FactSet Global Genomics and Immuno Biopharma Index | - |
| N° of holdings | 42 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2019 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the IDNA and TMED ETFs performed in 2026?
As of March 11, 2026, IDNA is up 14% year-to-date (YTD), while TMED has returned 0.13%. That puts IDNA better performer ahead so far this year.
Which ETF is attracting more investor money: IDNA or TMED?
Year-to-date, the IDNA ETF saw +$5M in flows, compared to +$3M for TMED.
Which ETF is bigger: IDNA or TMED?
As of March 11, 2026, IDNA holds $153.72 M in assets under management (AUM), while TMED manages $19.32 M.
What sectors do the IDNA and TMED ETFs invest in?
IDNA leans toward sectors like Health Care. Meanwhile, TMED focuses on Health Care.
What are the top holdings of the IDNA ETF and TMED ETF?
IDNA top holdings include MODERNA INC, BAYER AG and REVOLUTION MEDICINES INC. TMED holds in its top three: LILLY, UNITEDHEALTH GRP and GILEAD SCIENCES.
Which ETF is more diversified: IDNA or TMED?
IDNA holds 51 securities with 62.44% of its assets in the top 15. TMED has 80 securities and a top 15 weight of 56.46%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
